Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Hu14.18K322A
Trade Name
Drug Descriptions

Hu14.18K322A is a monoclonal antibody that binds GD2 and activates immune response to tumor cells expressing GD2, potentially resulting in increased tumor cell death (PMID: 32169872, PMID: 31601569).

CAS Registry Number NA
NCIT ID C80042


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Busulfan + Hu14.18K322A Busulfan Hu14.18K322A 0 1
Cisplatin + Cyclophosphamide + Doxorubicin + Etoposide + Hu14.18K322A + Vincristine Sulfate Cisplatin Cyclophosphamide Doxorubicin Etoposide Hu14.18K322A Vincristine Sulfate 0 0
Cyclophosphamide + Hu14.18K322A + Topotecan Cyclophosphamide Hu14.18K322A Topotecan 0 0
Hu14.18K322A Hu14.18K322A 0 1

Additional content available in CKB BOOST